Mood congruent psychotic symptoms and specific cognitive deficits in carriers of the novel schizophrenia risk variant at MIR-137

Neuroscience Letters

Volumn 532, Issue 1, 2013, Pages 33-38

  Cummings, E ^a   Donohoe, G ^a   Hargreaves, A ^a   Moore, S ^a   Fahey, C ^a   Dinan, T G ^b   McDonald, C ^c   O'Callaghan, E ^d   O'Neill, F A ^e   Waddington, J L ^f   Murphy, K C ^g   Morris, D W ^a   Gill, M ^a   Corvin, A ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^d DETECT   (Ireland)

^e QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^f ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^g BEAUMONT HOSPITAL   (Ireland)

Author keywords

Clinical symptoms; Genetics; Mir137; Psychosis

Indexed keywords

CHLORPROMAZINE; MICRORNA; MICRORNA 137; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; ATTENTION; BIPOLAR I DISORDER; COGNITIVE DEFECT; CONTROLLED STUDY; DSM-IV; EPISODIC MEMORY; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; BIPOLAR DISORDER; CASE-CONTROL STUDIES; COGNITION DISORDERS; GENETIC ASSOCIATION STUDIES; GENOTYPE; HETEROZYGOTE; HUMANS; MICRORNAS; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; YOUNG ADULT;

EID: 84871058700     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.08.065     Document Type: Article

References (22)

1. Angst J. Psychiatric diagnoses: the weak component of modern research. World Psychiatry: Official Journal of the World Psychiatric Association (WPA) 2007, 6:94-95.
2. Arts B., Jabben N., Krabbendam L., van Os J. Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives. Psychological Medicine 2008, 38:771-785.
3. Beveridge N.J., Cairns M.J. Microrna dysregulation in schizophrenia. Neurobiology of Disease 2012, 46:263-271.
4. Burdick K.E., Goldberg T.E., Cornblatt B.A., Keefe R.S., Gopin C.B., DeRosse P., Braga R.J., Malhotra A.K. The matrics consensus cognitive battery in patients with bipolar I disorder. Neuropsychopharmacology 2011, 36:1587-1592.
5. Craddock N., Jones I., Kirov G., Jones L. The bipolar affective disorder dimension scale (BADDS) - a dimensional scale for rating lifetime psychopathology in bipolar spectrum disorders. BMC Psychiatry 2004, 4:19.
6. Craddock N., O'Donovan M.C., Owen M.J. Psychosis genetics: modeling the relationship between schizophrenia, bipolar disorder, and mixed (or schizoaffective) psychoses. Schizophrenia Bulletin 2009, 35:482-490.
7. Donohoe G., Clarke S., Morris D., Nangle J.M., Schwaiger S., Gill M., Corvin A., Robertson I.H. Are deficits in executive sub-processes simply reflecting more general cognitive decline in schizophrenia?. Schizophrenia Research 2006, 85:168-173.
8. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for Dsm-Iv-Tr Axis I Disorders, Research Version, Patient Edition (Scid-I/P) 2002, Biometrics Research, New York State Psychiatric Institute, New York.
9. Genome-wide association study identifies five new schizophrenia loci. Nature Genetics 2011, 43:969-976.
10. Gilks W.P., Allott E.H., Donohoe G., Cummings E., Gill M., Corvin A.P., Morris D.W. Replicated genetic evidence supports a role for Homer2 in schizophrenia. Neuroscience Letters 2010, 468:229-233.
11. Kraepelin E. Manic-Depressive Insanity and Paranoia 1919, Livingstone, Edinburgh.
12. Kwon E., Wang W., Tsai L.H. Validation of schizophrenia-associated genes Csmd1, C10orf26, Cacna1c and Tcf4 as Mir-137 targets. Molecular Psychiatry 2011, 1-2.
13. Lichtenstein P., Yip B.H., Björk C., Pawitan Y., Cannon T.D., Sullivan P.F., Hultman C.M. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. The Lancet 2009, 373:234-239.
14. McGuffin P., Farmer A., Harvey I. A polydiagnostic application of operational criteria in studies of psychotic illness: development and reliability of the OPCRIT system. Archives of General Psychiatry 1991, 48:764-770.
15. Potkin S.G., Macciardi F., Guffanti G., Fallon J.H., Wang Q., Turner J.A., Lakatos A., Miles M.F., Lander A., Vawter M.P., Xie X. Identifying gene regulatory networks in schizophrenia. NeuroImage 2010, 53:839-847.
16. Silber J., Lim D.A., Petritsch C., Persson A.I., Maunakea A.K., Yu M., Vandenberg S.R., Ginzinger D.G., James C.D., Costello J.F., Bergers G., Weiss W.A., Alvarez-Buylla A., Hodgson J.G. Mir-124 and Mir-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Medicine 2008, 6:14.
17. Smrt R.D., Szulwach K.E., Pfeiffer R.L., Li X., Guo W., Pathania M., Teng Z.-Q., Luo Y., Peng J., Bordey A., Jin P., Zhao X. Microrna Mir-137 regulates neuronal maturation by targeting ubiquitin ligase mind Bomb-1. Stem Cells 2010, 28:1060-1070.
18. Szulwach K.E., Li X., Smrt R.D., Li Y., Luo Y., Lin L., Santistevan N.J., Li W., Zhao X., Jin P. Cross talk between microrna and epigenetic regulation in adult neurogenesis. The Journal of Cell Biology 2010, 189:127-141.
19. Van Snellenberg J.X., de Candia T. Meta-analytic evidence for familial coaggregation of schizophrenia and bipolar disorder. Archives of General Psychiatry 2009, 66:748-755.
20. Walters J.T.R., Corvin A., Owen M.J., Williams H., Dragovic M., Quinn E.M., Judge R., Smith D.J., Norton N., Giegling I., Hartmann A.M., Moller H.-J., Muglia P., Moskvina V., Dwyer S., O'Donoghue T., Morar B., Cooper M., Chandler D., Jablensky A., Gill M., Kaladjieva L., Morris D.W., O'Donovan M.C., Rujescu D., Donohoe G. Psychosis susceptibility gene Znf804a and cognitive performance in schizophrenia. Archives of General Psychiatry 2010, 67:692-700.
21. Williams N.M., Glaser B., Norton N., Williams H., Pierce T., Moskvina V., Monks S., Del Favero J., Goossens D., Rujescu D., Giegling I., Kirov G., Craddock N., Murphy K.C., O'Donovan M.C., Owen M.J. Strong evidence that Gnb1l is associated with schizophrenia. Human Molecular Genetics 2008, 17:555-566.
22. Wray N.R., Visscher P.M. Narrowing the boundaries of the genetic architecture of schizophrenia. Schizophrenia Bulletin 2010, 36:14-23.